4.5 Article

Materno-fetal outcome with PlGF above or below cutoff during second half of pregnancy in high-risk women

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Role of sFLT-1/PlGF ratio in predicting severe adverse materno-fetal outcome in high risk women

Manisha Kumar et al.

Summary: This study evaluated the role of angiogenic biomarkers in predicting severe adverse materno-fetal outcomes among women at high risk of preeclampsia. It found that an increased sFlt-1/PlGF ratio was a good predictive marker, especially for those who developed complications before 34 weeks.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2022)

Review Obstetrics & Gynecology

Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia A Systematic Review and Meta-analysis

Sean Lim et al.

Summary: The study systematically reviewed the performance of sFlt-1, PlGF, and the sFlt-1/PlGF ratio in predicting adverse outcomes in women with preeclampsia. PlGF and the sFlt-1/PlGF ratio showed prognostic promise for adverse outcomes in preeclampsia, but study heterogeneity limits their clinical utility.

OBSTETRICS AND GYNECOLOGY (2021)

Article Peripheral Vascular Disease

PlGF (Placental Growth Factor) Testing in Clinical Practice Evidence From a Canadian Tertiary Maternity Referral Center

Kelsey McLaughlin et al.

Summary: This study evaluated the association between maternal PlGF levels and pregnancy outcomes in high-risk pregnancies, finding a strong correlation between low PlGF levels and adverse outcomes such as preterm birth, early-onset preeclampsia, and stillbirth.

HYPERTENSION (2021)

Article Peripheral Vascular Disease

Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia

Holger Stepan et al.

HYPERTENSION (2020)

Article Obstetrics & Gynecology

Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension

Sarah Heimberger et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2020)

Review Obstetrics & Gynecology

The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care

Aris T. Papageorghiou et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)

Article Obstetrics & Gynecology

A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction

L. Ormesher et al.

PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)

Review Peripheral Vascular Disease

Placental growth factor and pre-eclampsia

K. Chau et al.

JOURNAL OF HUMAN HYPERTENSION (2017)

Article Medicine, General & Internal

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Daniel L. Rolnik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Acoustics

Consensus definition of fetal growth restriction: a Delphi procedure

S. J. Gordijn et al.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)

Review Obstetrics & Gynecology

Early Prediction of Preeclampsia

Leona C. Poon et al.

OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2014)

Article Obstetrics & Gynecology

Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

Ranjit Akolekar et al.

FETAL DIAGNOSIS AND THERAPY (2013)